Clinical Trials

Showing trials with last updates posted in 2022.

NCT02551718 | COMPLETED | NA
34 participants

High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2022-06-30
Start Date:
2015-09-11
Completion:
2020-06-19
Conditions
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Acute Myeloid Leukemia
  • Refractory Acute Leukemia of Ambiguous Lineage
Interventions
  • OTHER
  • GENETIC
  • DRUG
NCT02535325 | COMPLETED | PHASE1
17 participants

Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2022-06-30
Start Date:
2015-09-30
Completion:
2020-02-27
Conditions
  • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • Stage III Lung Adenocarcinoma AJCC v7
  • Stage III Lung Large Cell Carcinoma AJCC v7
  • Stage III Lung Non-Small Cell Cancer AJCC v7
  • Stage IIIA Lung Adenocarcinoma AJCC v7
  • Stage IIIA Lung Large Cell Carcinoma AJCC v7
  • Stage IIIA Lung Non-Small Cell Cancer AJCC v7
  • Stage IIIB Lung Adenocarcinoma AJCC v7
  • Stage IIIB Lung Large Cell Carcinoma AJCC v7
  • Stage IIIB Lung Non-Small Cell Cancer AJCC v7
  • Stage IV Lung Adenocarcinoma AJCC v7
  • Stage IV Lung Large Cell Carcinoma AJCC v7
  • Stage IV Lung Non-Small Cell Cancer AJCC v7
Interventions
  • RADIATION
  • DRUG
No Results Yet
NCT02529813 | COMPLETED | PHASE1
26 participants

CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2022-06-30
Start Date:
2015-12-16
Completion:
2021-11-08
Conditions
  • Acute Biphenotypic Leukemia
  • Acute Lymphoblastic Leukemia
  • Blasts 5 Percent or More of Bone Marrow Nucleated Cells
  • CD19 Positive
  • Minimal Residual Disease
  • Non-Hodgkin Lymphoma
  • Small Lymphocytic Lymphoma
  • Stage III Chronic Lymphocytic Leukemia
  • Stage IV Chronic Lymphocytic Leukemia
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT02049541 | COMPLETED | PHASE1
18 participants

Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2022-06-30
Start Date:
2014-07-21
Completion:
2018-09-12
Conditions
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • Nodal Marginal Zone B-cell Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Splenic Marginal Zone Lymphoma
  • Waldenström Macroglobulinemia
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page